About Retatrutide
Retatrutide is studied as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors, and is used in laboratory research focused on complex metabolic signaling. It is supplied as a lyophilized powder for investigations into receptor pharmacology, energy metabolism pathways, and glucose regulation mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.
Recent research on Retatrutide: Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.
Read Full Study on PubMedSustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome.
Recent research on Retatrutide: Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome.
Read Full Study on PubMedAdditional Studies
Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.
Recent research on Retatrutide: Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.
Read on PubMedCagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats.
Recent research on Retatrutide: Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats.
Read on PubMedObstructive sleep apnea, GLP-1 receptor agonist pharmacotherapy, and the oral microbiome: competing biological influences and implications for oral health monitoring.
Recent research on Retatrutide: Obstructive sleep apnea, GLP-1 receptor agonist pharmacotherapy, and the oral microbiome: competing biological influences and implications for oral health monitoring.
Read on PubMedCARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL.
Recent research on Retatrutide: CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL.
Read on PubMedFrom insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals.
Recent research on Retatrutide: From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals.
Read on PubMedComposition and Labelling Accuracy of Products Sold as Retatrutide in Australia.
Recent research on Retatrutide: Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia.
Read on PubMedRelated Research
Purchase Retatrutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.